Meilleure Health International Industry Group Management
Management criteria checks 4/4
Meilleure Health International Industry Group's CEO is Wen Chuan Zhou, appointed in Sep 2013, has a tenure of 11.17 years. total yearly compensation is HK$661.00K, comprised of 181.5% salary and -81.5% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth HK$8.14M. The average tenure of the management team and the board of directors is 8.3 years and 9.1 years respectively.
Key information
Wen Chuan Zhou
Chief executive officer
HK$661.0k
Total compensation
| CEO salary percentage | 181.5% |
| CEO tenure | 11.2yrs |
| CEO ownership | 0.8% |
| Management average tenure | 8.3yrs |
| Board average tenure | 9.1yrs |
Recent management updates
Recent updates
Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit
Oct 04
Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%
Sep 05Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet
Aug 30Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk
Jul 19Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around
Jun 17Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking
May 03Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality
Apr 04Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%
Feb 28Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)
Jan 23Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down
Aug 17Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)
Oct 18Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?
Sep 06Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist
Jul 12Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?
Sep 09Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue
May 15Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Apr 18Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?
Jan 29
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay
Dec 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$31m |
| Mar 31 2024 | n/a | n/a | HK$36m |
| Dec 31 2023 | HK$661k | HK$1m | HK$41m |
| Sep 30 2023 | n/a | n/a | HK$33m |
| Jun 30 2023 | n/a | n/a | HK$25m |
| Mar 31 2023 | n/a | n/a | HK$22m |
| Dec 31 2022 | HK$987k | HK$1m | HK$18m |
| Sep 30 2022 | n/a | n/a | HK$23m |
| Jun 30 2022 | n/a | n/a | HK$28m |
| Mar 31 2022 | n/a | n/a | HK$44m |
| Dec 31 2021 | HK$2m | HK$1m | HK$60m |
| Sep 30 2021 | n/a | n/a | HK$72m |
| Jun 30 2021 | n/a | n/a | HK$84m |
| Mar 31 2021 | n/a | n/a | HK$84m |
| Dec 31 2020 | HK$2m | HK$1m | HK$83m |
| Sep 30 2020 | n/a | n/a | HK$32m |
| Jun 30 2020 | n/a | n/a | -HK$19m |
| Mar 31 2020 | n/a | n/a | -HK$19m |
| Dec 31 2019 | HK$800k | HK$800k | -HK$20m |
| Sep 30 2019 | n/a | n/a | HK$31m |
| Jun 30 2019 | n/a | n/a | HK$83m |
| Mar 31 2019 | n/a | n/a | HK$82m |
| Dec 31 2018 | HK$540k | HK$540k | HK$81m |
| Sep 30 2018 | n/a | n/a | HK$81m |
| Jun 30 2018 | n/a | n/a | HK$81m |
| Mar 31 2018 | n/a | n/a | HK$81m |
| Dec 31 2017 | HK$540k | HK$540k | HK$80m |
Compensation vs Market: Wen Chuan's total compensation ($USD84.93K) is below average for companies of similar size in the Hong Kong market ($USD233.02K).
Compensation vs Earnings: Wen Chuan's compensation has been consistent with company performance over the past year.
CEO
Wen Chuan Zhou (41 yo)
11.2yrs
Tenure
HK$661,000
Compensation
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.4% HK$ 359.0m | |
| Executive Co-Chairman of the Board | 7.1yrs | no data | 1.83% HK$ 19.1m | |
| Vice Chairman & CEO | 11.2yrs | HK$661.00k | 0.78% HK$ 8.1m | |
| CFO & Company Secretary | 5.3yrs | no data | no data | |
| Human Resources Manager | no data | no data | no data |
8.3yrs
Average Tenure
61yo
Average Age
Experienced Management: 2327's management team is seasoned and experienced (8.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.4% HK$ 359.0m | |
| Executive Co-Chairman of the Board | 7.1yrs | no data | 1.83% HK$ 19.1m | |
| Vice Chairman & CEO | 11.3yrs | HK$661.00k | 0.78% HK$ 8.1m | |
| Independent Non-Executive Director | 11.3yrs | HK$180.00k | no data | |
| Non-Executive Director | 9.1yrs | HK$180.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.5yrs | HK$120.00k | no data |
9.1yrs
Average Tenure
61yo
Average Age
Experienced Board: 2327's board of directors are considered experienced (9.1 years average tenure).